Authors: Randolph JF, Sowers MF, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, Brockwell SE, Matthews KA.
Publication Year: 2005
Citation: J Clin Endocrinol Metab 2005;90(11):6106-12.
Vasomotor symptoms are experienced by 65-76% of women going through menopause. This study examined longitudinal changes in estradiol, FSH, testosterone, DHEA, sex hormone binding globulin, free estrogen index and free testosterone index, and found that only FSH levels were associated with the prevalence and frequency of vasomotor symptoms.